Aerovate Therapeutics, Inc.
NASDAQ:AVTE
2.72 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 23.491 | 22.397 | 54.197 | 4.573 | 3.514 |
| Short Term Investments
| 98.948 | 106.823 | 113.178 | 0 | 0 |
| Cash and Short Term Investments
| 122.439 | 129.22 | 167.375 | 4.573 | 3.514 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.793 | 0.295 | 0.24 | 0.103 | 0 |
| Total Current Assets
| 124.232 | 131.496 | 174.333 | 4.676 | 3.514 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 0.902 | 1.245 | 0.728 | 0.039 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.284 | 2.56 | 0.302 | 0 | 0 |
| Total Non-Current Assets
| 3.186 | 3.805 | 1.03 | 0.039 | 0 |
| Total Assets
| 127.418 | 135.301 | 175.363 | 4.715 | 3.514 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 2.396 | 2.575 | 1.208 | 0.618 | 0.542 |
| Short Term Debt
| 0.42 | 0.385 | 0.192 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 1.007 | 0 | 0 |
| Other Current Liabilities
| 14.821 | 4.822 | 0.143 | 1.156 | 0.115 |
| Total Current Liabilities
| 17.637 | 7.782 | 2.55 | 1.774 | 0.657 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 0.255 | 0.705 | 0.382 | 0 | 2.5 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.07 | 0.071 | 0.013 | 0 | 4 |
| Total Non-Current Liabilities
| 0.325 | 0.776 | 0.395 | 16.285 | 6.5 |
| Total Liabilities
| 17.962 | 8.558 | 2.945 | 18.059 | 7.157 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 175.363 | 16.285 | 4 |
| Common Stock
| 0.003 | 0.002 | 0.002 | 0 | 0 |
| Retained Earnings
| -163.424 | -87.903 | -36.392 | -13.407 | -3.643 |
| Accumulated Other Comprehensive Income/Loss
| 0.237 | -0.466 | -0.059 | 0 | 0 |
| Other Total Stockholders Equity
| 272.64 | 215.11 | 33.504 | -16.222 | -4 |
| Total Shareholders Equity
| 109.456 | 126.743 | 172.418 | -13.344 | -3.643 |
| Total Equity
| 109.456 | 126.743 | 172.418 | -13.344 | -3.643 |
| Total Liabilities & Shareholders Equity
| 127.418 | 135.301 | 175.363 | 4.715 | 3.514 |